Danish pharmaceutical company Novo Nordisk (NYSE: NVO) is pioneering a new wave of medical treatment for diabetes and obesity ...

A study shows a 25.6 per cent decline in weight-loss surgeries as more Americans turn to GLP-1 medications like Wegovy and ...

The active ingredient in Ozempic and Wegovy has once again proven to have health effects outside of weight loss in a huge ...

Study of those who started taking blockbuster weight loss drugs in 2021 suggests patients need support services, not just the ...

The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...

Meds like Wegovy are all over the news. But are they right for you, especially if you're older than the average user?By Are ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

The findings spell an uncertain future for hospitals and clinics that derive a significant portion of their revenues from ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries t ...

The U.K. government issued a new warning aimed at the misuse of GLP-1 therapies by those who don’t qualify for the meds but are instead using them for quick-fix weight loss.

Nationally, employers could see total health insurance costs rise 5.8% on average in 2025. KC won't be spared costlier ...

Semaglutide, the active ingredient in the diabetes and weight loss drugs Ozempic and Wegovy, could lower the risk for ...